Levi & Korsinsky is investigating the Board of Directors of Titanium Metals Corporation (“Titanium Metals” or the “Company”) (NYSE: TIE) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Precision Castparts Corporation (NYSE: PCP).
Click here to learn more about the investigation
, or call: 877-363-5972. There is no cost or obligation to you.
Under the terms of the transaction, Titanium Metals shareholders will receive $16.50 for each share of Titanium Metals stock they own. The transaction has a total approximate value of $2.9 billion. Shareholders representing a combined 45% of the Company’s shares have already agreed to tender their shares. The investigation concerns whether the Titanium Metals Board of Directors breached their fiduciary duties to stockholders by failing to adequately shop the Company before entering into this transaction and whether Precision Castparts Corporation is underpaying for Titanium Metals shares, thus unlawfully harming Titanium Metals stockholders. In particular, at least one analyst set a price target for Titanium Metals stock at $20.00 per share.
If you own common stock in Titanium Metals and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at
or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit
Levi & Korsinsky is a national firm with offices in New York and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.